蜂毒素分子的改造及其基因在毕赤酵母中的表达

为获得保留有抗菌活性而降低溶血作用的蜂毒素,对蜂毒素的分子结构进行了改造.将第5位的Val变为Arg,第15位Ala变为Arg,删除了第16位的Leu.用PCR技术获得了改造后的蜂毒素基因,将其克隆入酵母表达载体pPICZa-A,获得重组表达质粒pPICZa-A-MEA.该质粒转化毕赤酵母菌GS115,甲醇诱导下表达,发酵上清液经抑菌活性、溶血活性测定及亲和层析纯化,结果表明,蜂毒素基因成功地在毕赤酵母中表达,经改造后表达的蜂毒素保留了抗菌活性且溶血活性显著降低,经纯化后用Bradford法测定表达蜂毒素的含量约为0.29mg/ml.     

蜂毒素分子的改造及其基因在毕赤酵母中的表达

为获得保留有抗菌活性而降低溶血作用的蜂毒素,对蜂毒素的分子结构进行了改造。将第5位的Val变为Arg,第15位Ala变为Arg,删除了第16位的Leu。用PCR技术获得了改造后的蜂毒素基因,将其克隆入酵母表达载体pPICZa-A,获得重组表达质粒pPICZa-A-MEA。该质粒转化毕赤酵母菌GS115,甲醇诱导下表达,发酵上清液经抑菌活性、溶血活性测定及亲和层析纯化,结果表明,蜂毒素基因成功地在毕赤酵母中表达,经改造后表达的蜂毒素保留了抗菌活性且溶血活性显著降低,经纯化后用Bradford法测定表达蜂毒素的含量约为0.29mg／ml。     

改造的蜂毒素基因在毕赤酵母中分泌表达及培养条件研究

对蜂毒素基因进行改造后,通过PCR方法获得新蜂毒素基因(MEA),将其克隆到表达载体pPICZa—A,而后将重组表达载体pPICZa-A-MEA转化GS115,筛选获得重组酵母菌．对GS115-ME经甲醇诱导表达并对培养条件进行优化探讨．对改造的蜂毒素进行了溶血活性、热稳定性及酸碱稳定性测定．结果表明,蜂毒素基因成功地在毕赤酵母中表达,经改造的蜂毒素在保留了抗菌活性的同时溶血活性降低20倍左右,同时还具有良好的热稳定性和酸碱稳定性．     

人防御素6基因的克隆、亚克隆及在酵母中的分泌表达

探讨人防御素6(HD-6)在毕赤酵母中表达的可行性,为进一步研究HD6的功能提供理论依据和实验基础。采用PCR方法,设计引物从cDNA文库中扩增出人α防御素6基因片段,并将其插入到克隆载体pMD-18T中,再与毕赤酵母表达载体pPICZαA重组,以得到重组的HD-6酵母表达载体pPICZαA/HD-6,并进行琼脂糖电泳和测序鉴定。再将构建好的毕赤酵母重组表达质粒pPICZαA/HD-6经SacⅠ线性化后,应用LiCl法转化毕赤酵母菌株GS115感受态中,Zeocin平板筛选,PCR鉴定转化子。经摇瓶发酵和甲醇诱导,SDSPAGE分析重组HD-6的表达。从cDNA文库中扩增出的HD-6基因片断大小正确;电泳和测序结果均证明已将此片段克隆到酵母表达载体pPICZαA内;线性化的重组质粒pPICZαA/HD-6成功转化进入毕赤酵母感受态中,PCR鉴定结果与预期相符;蛋白电泳证实重组HD-6在酵母中获得分泌表达。提示重组HD-6可以在毕赤酵母中实现分泌表达。     

鸡碳酸酐酶4基因在毕赤酵母中的表达

[目的]通过毕赤酵母的表达获得鸡碳酸酐酶4(CAⅣ)蛋白。[方法]根据鸡CAⅣ的序列,结合毕赤酵母密码子的偏好性,合成CAⅣ基因。将CAⅣ基因克隆到pPICZαA真核表达载体,获得重组表达质粒pPICZαA-CAⅣ。将其电转毕赤酵母GS115后,获得重组毕赤酵母菌GS115/pPICZαA-CAⅣ。用终浓度为1%的甲醇对重组阳性菌进行诱导表达,通过SDS-PAGE和Westernblot法检测蛋白的表达,并用Ni离子亲和层析法对表达出的蛋白进行纯化。[结果]成功构建了表达载体pPICZαA-CAⅣ,转化重组酵母菌后可分泌出36kDa左右的CAⅣ蛋白,并通过Ni离子亲和层析法获得了单一性的目的蛋白CAⅣ。[结论]获得分子量约36kDa的鸡CAⅣ蛋白。     

水稻白叶枯病抗性基因Xα21和稻瘟病抗性基因Pi-d2激酶蛋白质在毕赤酵母中的表达及条件优化

[目的]白叶枯病和稻瘟病是最主要的水稻病害,Xα21是水稻白叶枯病抗性基因,Pi-d2是稻瘟病抗性基因,二者都编码类受体激酶蛋白质.本研究旨在毕赤酵母系统中表达XA21和PI-D2激酶蛋白质.[方法]用Xα21和Pi-d2的激酶区PCR产物,构建了pPICZαA-Xα21K、pPICZαA-Pi-d2K重组质粒,酶切及测序验证后,将重组质粒线性化,转化到毕赤酵母菌株中,系统地比较了不同酵母菌株(KM71、GS115、X33),不同甲醇浓度(1%、2%、3%),不同pH(pH5、pH6、pH7、pH8)值,不同诱导时间(24 h、48 h、72 h)条件下激酶蛋白质的表达情况.[结果]XA21和PI-D2激酶蛋白质可以在毕赤酵母中表达,但表达的蛋白质不能分泌到培养基上清中,而只能在菌体中检测到,对表达条件的系统比较发现,毕赤酵母菌株KM71和X33、2%的甲醇诱导浓度、pH5和48 h以上的诱导时间有利于激酶蛋白质的表达,最后我们在酵母裂解物上清中获得了纯化的考染可见的激酶蛋白质.[结论]在毕赤酵母中表达了XA21和PI-D2激酶蛋白质,为下一步生化特性研究奠定了基础.     

里氏木霉纤维二糖水解酶Ⅱ在毕赤酵母中的高效表达

本工作采用巴氏毕赤酵母Pichiapastoris表达系统进行了里氏木霉Trichodermareesei纤维二糖水解酶Ⅱ(CellobiohydrolaseII)的表达。用RT-PCR的方法从经稻草粉诱导的里氏木霉培养物中分离出纤维二糖水解酶Ⅱ的基因,将其插入到巴氏毕赤酵母的表达载体pPICZαA中,并使之处于α-因子信号肽序列的下游,得到重组质粒pPICZαA-cbh2。通过电穿孔的方法用线性化的pPICZαA-cbh2转化巴氏毕赤酵母GS115菌株,经过大量筛选后得到可以高效表达纤维二糖水解酶的毕赤酵母菌株P.pastorisCBHⅡ1。在甲醇诱导的条件下培养P.pastorisCBHⅡ1,培养液中的CMC活性可达到3.82U/mL,SDS-PAGE分析结果表明纤维二糖水解酶在P.pastorisCBHⅡ1中的表达量远远高于里氏木霉。对表达产物进行了LC-MS分析,结果表明所表达的蛋白为里氏木霉的纤维二糖水解酶。     

犬细小病毒VP2基因的克隆及其在毕赤酵母中的表达

目的表达犬细小病毒VP2蛋白（CPVVP2）,用于犬细小病毒病的诊断、疫苗研制和VP2蛋白功能研究。方法采用PCR方法对CPVVP2基因进行扩增,将CPVVP2基因克隆到毕赤酵母（Pichiapastoris）分泌表达载体pPICZαA中,构建真核重组表达载体pPICZαA—VP2,将该重组质粒线性化后,转化毕赤酵母菌GS115中,在甲醇诱导下表达CPVVP2,SDS-PAGE和Western blotting鉴定表达蛋白。结果成功扩增了CPVVP2基因,构建了真核重组表达载体pPICZαA-VP2在毕赤酵母菌中表达出约64．35kD蛋白。Western blotting鉴定表明,表达VP2蛋白与犬细小病毒阳性血清有反应性。结论在毕赤酵母中成功地表达了CPVVP2蛋白,能被犬细小病毒阳性血清识别。     

里氏木霉内切葡萄糖苷酶Ⅳ在毕赤酵母中的表达

进行了内切葡萄糖苷酶Ⅳ（EGⅣ）在毕赤酵母（Pichia pastoris）表达系统中的表达。采用RT—PCR的方法从里氏木霉（Trichoderma reesei）中分离到eg4基因。将eg4基因与毕赤酵母表达载体pPICZαA连接,得到重组质粒pPICZαA-eg4。将该重组质粒线性化后转化毕赤酵母GS115,eg4基因通过同源重组被整合到毕赤酵母的染色体上,并处于酵母α因子的下游,得到重组菌株P.pastoris—EGⅣ1。在甲醇诱导下,重组菌株P.pastoris-EGⅣ1可以合成并分泌EGⅣ,培养液的CMC活力达到2．11U／mL。     

黄瓜膨胀素的重组表达及活性分析

目的:提高纤维素的酶水解效率和开发高效的纤维素酶水解过程。方法:采用RT-PCR方法从黄瓜胚轴细胞中分离了膨胀素S1的cDNA,并使之与毕赤酵母表达质粒pPICZ(A连接,形成重组质粒pPICZ(A-exs1。通过电转化方法,用质粒pPICZ(A-exs1转化巴氏毕赤酵母GS115,得到重组菌株P.pastoris-exs1。在该重组菌株中,膨胀素的基因通过同源重组整合在毕赤酵母的染色体上,并处于毕赤酵母甲醇氧化酶启动子的下游。重组菌株P.pastoris-exs1在甲醇诱导下可合成并分泌膨胀素。结果:培养上清液没有纤维素酶活性,但具有破坏滤纸纤维素结晶结构的能力。培养上清液与里氏木霉纤维素酶等量混合后,可使纤维素酶的滤纸酶活力提高50%。结论:采用巴氏毕赤酵母GS115重组成功表达了黄瓜膨胀素,其表达产物可以促进纤维素酶对滤纸的水解。     

Melittin lysis of red cells

Summary This paper describes experiments designed to explore interactions between human red blood cell membranes and melittin, the main component of bee venom. We found that melittin binds to human red cell membranes suspended in isotonic NaCl at room temperature, with an apparent dissociation constant of 3×10^–8 m and maximum binding capacity of 1.8×10⁷ molecules/cell. When about 1% of the melittin binding sites are occupied, cell lysis can be observed, and progressive, further increases in the fraction of the total sites occupied lead to progressively greater lysis in a graded manner. 50% lysis occurs when there are about 2×10⁶ molecules bound to the cell membrane. For any particular extent of melittin binding, lysis proceeds rapidly during the first few minutes but then slows and stops so that no further lysis occurs after one hour of exposure of cells to melittin. The graded lysis of erythrocytes by melittin is due to complete lysis of some of the cells, since both the density and the hemoglobin content of surviving, intact cells in a suspension that has undergone graded melittin lysis are similar to the values observed in the same cells prior to the addition of melittin. The cells surviving graded melittin lysis have an increased Na and reduced K, proportional to the extent of occupation of the melittin binding sites. Like lysis, Na accumulation and K loss proceed rapidly during the first few minutes of exposure to melittin but then stops so that Na, K and hemoglobin content of the cells remain constant after the first hour. These kinetic characteristics of both lysis and cation movements suggest that melittin modifies the permeability of the red cell membrane only for the first few minutes after the start of the interaction. Direct observation of cells by Nomarsky optics revealed that they crenate, become swollen and lyse within 10 to 30 sec after these changes in morphology are first seen. Taken together, these results are consistent with the idea that melittin produces lysis of human red cells at room temperature by a colloid osmotic mechanism.     

Characterization of Melittin Effects in Synaptosomes

The effects of melittin at increasing concentrations on: [³H]GABA release from mouse brain synaptosomes; on the radioactivity released from [³H]arachidonic acid labeled synaptosomal membranes; on synaptosomes ultrastructure and on the leakage of the cytoplasmic marker, lactate-dehydrogenase (LDH) was investigated. Melittin 0.3, 1, 3, 7, and 10 M progressively increases [³H]GABA release, but the efficacy of melittin is decreased when the amount of tissue exposed to a constant concentration of the toxin increases. The release of [³H]GABA induced by melittin below 3 M is Ca²⁺ dependent, but not that induced by the higher concentrations. The Ca²⁺ dependent fraction of the [³H]GABA released by 0.3 M melittin is selectively inhibited by 10 M quinacrine and 1 M nordihydroguaiaretic acid (NDGA) and facilitated by 3 M indomethacin, whereas the Ca²⁺ independent fraction of the [³H]GABA released by melittin is not. In the presence of Ca²⁺, melittin 0.3, 1 and 10 M progressively increases [³H]arachidonic acid release over control release, but the effectiveness of melittin is also decreased as the amount of tissue increases. No apparent changes in synaptosomes ultrastructure are observed in 0.3 M treated synaptosomes, but a noticeable disorganization is produced in 10 M melittin-treated synaptosomes, independently on the presence of external Ca²⁺. LDH activity only increases over control activity in the supernatant solutions of 10 M melittin treated synaptosomes, also in a Ca²⁺ independent manner. Our interpretation of these results is that the Ca²⁺-dependent, pharmacologic sensitive component of melittin-induced release of [³H]GABA, unmasked when 0.3 M melittin was used, involves the activation of a Ca²⁺-dependent type of membrane PLA₂. The Ca²⁺-independent release of [³H]GABA is in contrast, highly probable to be due to the membrane perturbation produced by complex melittin/lipid interactions.     

Melittin inhibition and uncoupling of spinach thylakoids

Melittin has been found to inhibit a photosystem I reaction (diaminodurene to methylviologen) in much the same way that it inhibits sequential electron transport through both photosystems (water to methylviologen). At much lower concentrations melittin uncouples ATP synthesis. Melittin inhibition and uncoupling are found to be irreversible indicating very tight association between melittin and the membrane. Melittin inhibits the light-induced proton pump and the light-induced thylakoid Mg⁺²-ATPase activity as well as the Ca⁺²-ATPase activity of isolated coupling factor. The results are consistent with both a conventional model where the uncoupling by melittin is related to its lytic properties and a model wherein melittin interacts directly with coupling factor causing an uncoupling condition.     

Melittin interactions with adenylate cyclase

Melittin, a basic polypeptide from bee venom, inhibits basal and thyrotropin-stimulated adenylate cyclase of beef thyroid membranes with a K_i ≈ 10 μM. Although this property resides in the basicC-terminal and not the N-terminal portion of the molecule, inhibition is due primarily to its detergent-like nature rather than the charge effects. There is also a small enhancing effect of both basal and thyrotropin-stimulated adenylate cyclase of 0.3–3 μM melittin.     

HIV Capsid and Protease,New Targets of Melittin

International Journal of Peptide Research and Therapeutics - Melittin is a 26 amino acid amphipathic peptide, the main part of a bee venom. It has been confirmed that melittin can act against a...     

蜂毒肽的溶血作用与红细胞膜上两种酶活性变化的关系

从蜂毒肽作用于红细胞膜上的Na^＋-K^＋-ATPase和葡萄糖-6-磷酸脱氢酶(G-6-PD)活性变化的角度,利用分光光度法测定酶活性,研究蜂毒肽与红细胞及膜作用过程中可能的靶点,讨论了蜂毒肽溶血过程与RBC膜上2种酶活性的变化．结果发现,蜂毒肽抑制RBC膜上酶活性的主要模式为附着/插入质膜与游离态并存模式,附着/插入质膜中的作用大于游离态的作用．Na^＋-K^＋-ATPase的K⁺结合位点是蜂毒肽的1个作用靶点．蜂毒肽插膜过程与其对此酶的作用随时间延长同步发生．蜂毒肽通过作用于葡萄糖-6-磷酸和NADP使G-6-PD的催化受到缓慢抑制,蜂毒肽形成四聚体的程度与酶活性密切相关．EDTA抑制蜂毒肽聚集,干扰蜂毒肽作用于G-6-P,蜂毒肽作用于底物G-6-P及辅酶NADP的生化机理相似,蜂毒肽抑制作用与G-6-PD的结构无关.